Ergoteles’s PetMed Express PETS Stock Holding History

Ergoteles’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-136,320	Closed	-$1.88M	–	619
2023 Q2	$1.88M	Buy	136,320 +90,820	+200%	+$1.36M	0.09%	290
2023 Q1	$739K	Buy	+45,500	New	+$857K	0.03%	605
2021 Q4	–	Sell	-27,510	Closed	-$739K	–	1510
2021 Q3	$739K	Buy	+27,510	New	+$792K	0.03%	462

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Ergoteles's PETS Position: Q3 2023 in Review

Ergoteles sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 136,320 shares — an estimated $1.88M sold.

Ergoteles first reported a position in PETS in Q3 2021 and held it in 3 quarters. The position peaked at $1.88M in Q2 2023. 139 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

Ergoteles reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 136,320 PetMed Express shares in Q3 2023, an estimated $1.88M.
Ergoteles first reported a position in PetMed Express in Q3 2021 and held it in 3 quarters.
Ergoteles's PetMed Express position peaked at $1.88M in Q2 2023.
139 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.